Bristol Myers Squibb stock rocketed Monday after AbbVie's experimental schizophrenia treatment failed in a pair of midstage studies.

Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at the Food and Drug ...

Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...

Cheese processed at plant in Lena, Illinois, may be tainted by bacteria that can cause serious and fatal infections.

Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...

Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

AbbVie (NYSE:ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia missed its primary endpoint, sending shares in the drugmaker down sharply in premarket US ...

From family planning to hospital bills, the new Trump administration has the potential to affect a wide range of policies in ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...